muscle aging

The race to conquer obesity is entering a new phase, one where simply shedding pounds isn’t enough. Swedish biotech Atrogi has begun dosing subjects in a human trial for ATR-258, a novel drug candidate aiming to tackle a critical, often overlooked consequence of weight loss: muscle loss. This isn’t just about aesthetics; preserving muscle mass … Read more